Satsuma Pharmaceuticals, Inc.

RA CAPITAL MANAGEMENT, L.P.

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

5,914,252

Value ($000)

4,131

Weight

0.1%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	4,131	0.1%	5,914,252	3/31/2023
2022 Q4	2/14/2023	5,323	0.1%	5,914,252	12/31/2022
2022 Q3	11/14/2022	35,486	0.8%	5,914,252	9/30/2022
2022 Q2	8/15/2022	24,485	0.7%	5,914,252	6/30/2022
2022 Q1	5/16/2022	22,474	0.5%	5,914,252	3/31/2022
2021 Q4	2/14/2022	26,614	0.5%	5,914,252	12/31/2021
2021 Q3	11/15/2021	27,560	0.4%	5,914,252	9/30/2021
2021 Q2	8/16/2021	41,695	0.7%	5,914,252	6/30/2021
2021 Q1	5/17/2021	34,953	0.5%	5,914,252	3/31/2021
2020 Q4	2/16/2021	21,583	0.3%	4,681,858	12/31/2020
2020 Q3	11/16/2020	18,212	0.3%	4,681,858	9/30/2020
2020 Q2	8/14/2020	134,650	2.6%	4,681,858	6/30/2020
2020 Q1	5/15/2020	100,754	3.2%	4,681,858	3/31/2020
2019 Q4	2/14/2020	92,139	2.8%	4,681,858	12/31/2019